Minireview: CNS Mechanisms of Leptin Action

被引:122
|
作者
Flak, Jonathan N. [1 ]
Myers, Martin G., Jr. [1 ,2 ]
机构
[1] Univ Michigan, Dept Internal Med, Div Metab Endocrinol & Diabet, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA
基金
美国国家卫生研究院;
关键词
VENTRAL PREMAMMILLARY NUCLEUS; RECEPTOR NEURONS; ENERGY-BALANCE; GLUCOSE-HOMEOSTASIS; SIGNAL TRANSDUCER; FOOD-INTAKE; ARCUATE NUCLEUS; GENE-EXPRESSION; SOLITARY TRACT; FEMALE MICE;
D O I
10.1210/me.2015-1232
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Leptin is an adipocytokine that circulates in proportion to body fat to signal the repletion of long-term energy stores. Leptin acts via its receptor, LepRb, on specialized neuronal populations in the brain (mainly in the hypothalamus and brainstem) to alter motivation and satiety, as well as to permit energy expenditure and appropriate glucose homeostasis. Decreased leptin, as with prolonged caloric restriction, promotes a powerful orexigenic signal, decreases energy use via a number of neuroendocrine and autonomic axes, and disrupts glucose homeostasis. Here, we review what is known about cellular leptin action and focus on the roles for specific populations of LepRb-expressing neurons for leptin action.
引用
收藏
页码:3 / 12
页数:10
相关论文
共 50 条
  • [41] ACTION OF SUCCINYLDICHOLINE ON CNS
    GLEY, P
    ROYETLEBLANC, M
    COMPTES RENDUS DES SEANCES DE LA SOCIETE DE BIOLOGIE ET DE SES FILIALES, 1975, 169 (05): : 1185 - 1189
  • [42] Leptin Action in the Brain Normalizes Diabetic Hyperglycemia Via Insulin-Independent Mechanisms
    German, Jonathan P.
    Wisse, Brent E.
    Thaler, Joshua P.
    Matsen, Miles E.
    Taborsky, Gerald J., Jr.
    Schwartz, Michael W.
    Morton, Gregory J.
    DIABETES, 2010, 59 : A432 - A432
  • [43] Leptin therapy improves insulin-deficient type 1 diabetes by CNS-dependent mechanisms in mice
    Fujikawa, Teppei
    Chuang, Jen-Chieh
    Sakata, Ichiro
    Ramadori, Giorgio
    Coppari, Roberto
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (40) : 17391 - 17396
  • [44] Neuroprotective Potential of Silymarin against CNS Disorders: Insight into the Pathways and Molecular Mechanisms of Action
    Borah, Anupom
    Paul, Rajib
    Choudhury, Sabanum
    Choudhury, Amarendranath
    Bhuyan, Bornalee
    Das Talukdar, Anupam
    Choudhury, Manabendra Dutta
    Mohanakumar, Kochupurackal P.
    CNS NEUROSCIENCE & THERAPEUTICS, 2013, 19 (11) : 847 - 853
  • [45] Enhancement of CNS activity and withdrawal reflexes by general anaesthetics: Specific excitatory mechanisms of action
    Roth, SH
    Archer, DP
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (01) : R172 - R172
  • [46] Repair mechanisms in the CNS
    Siegel, DA
    Huang, M
    Walkley, S
    ANAESTHESIA, PAIN, INTENSIVE CARE AND EMERGENCY MEDICINE - APICE 14, 2000, : 377 - 385
  • [47] Taurinamide derivatives - Drugs with the metabolic type of action - Minireview
    Sapronov, Nikolay S.
    Gavrovskaya, Ludmila K.
    TAURINE 6, 2006, 583 : 509 - 513
  • [48] Minireview: Putting Physiology Back into Estrogens' Mechanism of Action
    Koos, Robert D.
    ENDOCRINOLOGY, 2011, 152 (12) : 4481 - 4488
  • [49] The molecular mechanisms of cellular tolerance to δ-opioid agonists -: A minireview
    Varga, EV
    ACTA BIOLOGICA HUNGARICA, 2003, 54 (02): : 203 - 218
  • [50] The Molecular Mechanisms of Cellular Tolerance to δ-Opioid AgonistsA Minireview
    Eva V. Varga
    Acta Biologica Hungarica, 2003, 54 : 203 - 218